A large scale study was done by the Age-Related Eye Disease Study Research Group. The study involved 3,640 patients with an average follow-up of 6.3 years. Participants were randomly assigned to receive daily oral tablets containing:
Antioxidants: Vitamin C at 500 mg, Vitamin E at 400 IU, and Beta Carotene at 15 mg.
Zinc: at 80 mg.
Copper: at 2 mg.
Results showed a 25%-30% reduction in the progression of AMD in patients taking this combination of vitamins and minerals.
GREGORY CHANDLER, Attorney at Law
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment